Upcoming events

Educational Interviews

Educational interviews are at the centre of the PCR experience. Whether it’s an expert opinion on a new technique and tool or any of the key topics that interest you, you can find it here. Available online during and after every course, we spotlight the latest procedures, devices, tools and techniques on TAVI, stents and scaffolds, below the knee, LAA closure, STEMI, chronic heart failure, mitral valve replacement and repair and other topics.

Filter By

192 results

Renal angioplasty and arteriovenous-fistula creation for hypertension

12 Jul 2017 - From EUROPCR 2017

Interventions for hypertension – where do we stand today? Can the reality of clinical practice differ from trials? S. Ewen, F. Sharif and M. D. Lobo review current evidence and experience with a look at the growing instance of renal artery stenosis or the possibility of a “mechanical” approach to treating resistant hypertension. Is there an association between renal artery stenosis and hypertension or chronic kidney disease? Can certain patients benefit from revascularisation? Why would AV fistula creation reducing systemic vascular resistance reduce blood pressure? What is the ROX CONTROL HTN study and how does it point the way to future avenues of treatment? Learn more.

How intravascular imaging can optimise PCI results

11 Jul 2017 - From EUROPCR 2017

Complex PCI, STEMI...does using IVUS really reduce major adverse cardiovascular events? Join C. Cook, Z. Ali and G. Guagliumi as they review the proper way to use this “irrefutable” imaging tool. Does IVUS have a role throughout a procedure? How should you prepare and map your strategy in advance? Leanr why they characterise this as “the essence of decision–making”? What does the future hold in store for these technologies? How can we move to more “objective” measurements? What is the importance of the upcoming trial comparing high-risk patients and high-risk lesion randomised to angiography against OCT? Learn more here…

How to treat patients with popliteal and common femoral artery lesions

12 Jul 2017 - From EUROPCR 2017

With peripheral interventions becoming more widespread, what are the challenges facing specialists in treating complex situations? C. Cook speaks with leading peripheral expert A. Micari about what he describes as “the worst part of the leg’s vascular tree”. Learn about the difficulties inherent in treating lesions in arteries subject to the forces of compression, flexion and torsion at the same time, or how restenosis has been an historic threat. What innovative devices and techniques are becoming available today that could offer a valid choice instead of surgery? What are our unmet needs and why is the field “ripe” for future developments? Watch now.

Bifurcation stenting, when do I need two stents?

11 Jul 2017 - From EUROPCR 2017

Treating bifurcation lesions is a challenge, and the need to convert to a two-stent strategies can be daunting. Join experts G. G. Toth, T. Johnson and F. Mangiacapra as they discuss their own insights and suggestions, reminding us to never forget the provisional approach. What percentage of cases might necessitate converting to a two-stent technique? What elements in anatomy, lesion or the type of patient might require this change? Which two-stent strategy should you begin with – and practice? What imaging tools are useful and what possible role does functional assessment play? Watch video and find out…

Management of patients with multilevel atherosclerosis

11 Jul 2017 - From EUROPCR 2017

While we are used to treating coronary artery disease, interventional cardiologists need to keep in mind that many of these patients have a silent form of vascular involvement because of atherosclerosis. S. Redwood, F. Ribichini and M. Roffi focus on this complex topic and the implications of taking charge of patients with diffuse disease. What current evidence exists in this often older and sicker population? On what level should management begin? Why is the best treatment one that is provided by a clinician working with a team of dedicated specialists in a “patient-centred” approach? Learn the details here…

Strategies and devices for the treatment of complex artoiliac lesions

11 Jul 2017 - From EUROPCR 2017

From defining the disease, choosing the best patient and planning the intervention itself, all points are covered with peripheral experts E. Stabile and A. Sauguet in this detailed discussion. Learn why symptoms are not enough to classify your patient, why duplex echo followed by angio-CT are essential and what they tell us about anatomy, the complexity of the lesion or the amount of the calcium.  Learn why planning strategy implies choosing the access route and why, in some cases, two different access sites might be required. Does device choice drive strategy as well? More here…

Bioresorbable scaffolds, an evolving technology

10 Jul 2017 - From EUROPCR 2017

A stent that does its job and then disappear has long been an unmet need and dream of interventional cardiologists. Join J. Ormiston, A. Al Nooryani and W. Wijns as they review the state-of-the-art of these elusive devices beginning with their composition and covering the issues and implications of scaffold thickness, device cost or procedural complexity. Today, with limited trials and data, faced with the fear of a small percentage of stent thrombosis, do these devices have a true utility? What is PSP and how does that optimise the use of current BRS? What does the future hold for this new technology? Watch now…

Cardiac regenerative strategies for interventionalist

10 Jul 2017 - From EUROPCR 2017

Can we create new myocardia and develop a “cure” for heart failure? Faced with an array of medical and device treatment, G.G Toth, D. Burkhoff and W. Wojakowski underline what is missing in current strategies apart from heart transplants – Do they actually have an effect on the missing or remodeled myocytes? How could interventionalists replace muscle cells that have been destroyed or altered?  Current and past cell therapies are reviewed along with emerging data, types of cells tested as well as looking at delivery techniques or specific patient groups. Critical problems and limitations facing research are discussed to understand why advancing this therapy has been unsuccessful. Learn more…

Fully percutaneous abdominal aortic aneurysm treatment

10 Jul 2017 - From EUROPCR 2017

With aging populations, the prevalence of abdominal aortic aneurysm (AAA) is increasing. New technologies promise successful, fully percutaneous treatments of AAA which can patient benefit a majority of patients and these treatment should find their natural place in the work of all interventional cardiologists. Learn how – and why – in this conversation with P. Musialek, E. Vuruskan and A. Cremonesi as they discuss such points as imaging tools and the selection criteria such as anatomy that allow you to match the ideal patient with available devices and techniques. With up to 80% of patients eligible for these treatments today, shouldn’t you watch now?

PCR London Valves: Imaging at the core


Listen to PCR London Valves Course Director N. Piazza as he introduces the guidelines that will drive this year’s focus on Imaging including a case-based approach and device-specific learning. This focus will begin with Imaging Day on Sunday 24 and will pursue throughout the Course.